American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

Gastroenterology. 2013 Dec;145(6):1459-63. doi: 10.1053/j.gastro.2013.10.047.
No abstract available

Keywords: AGA; American Gastroenterological Association Institute; CD; Crohn's disease; Development and Evaluation; GRADE; Grading of Recommendations Assessment; PICO; TNF; and outcome; comparator; intervention; population; tumor necrosis factor.

Publication types

  • Practice Guideline

MeSH terms

  • Azathioprine / therapeutic use*
  • Crohn Disease / drug therapy*
  • Gastroenterology
  • Humans
  • Mercaptopurine / therapeutic use*
  • Methotrexate / therapeutic use*
  • Remission Induction
  • Societies, Medical
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • United States


  • Tumor Necrosis Factor-alpha
  • Mercaptopurine
  • Azathioprine
  • Methotrexate